Kevin E. Weddington

Array ( [id] => 1031192 [patent_doc_number] => 06878745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-12 [patent_title] => 'Selective preventives/remedies for progressive lesions after organ damage' [patent_app_type] => utility [patent_app_number] => 10/239783 [patent_app_country] => US [patent_app_date] => 2001-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25030 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 319 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/878/06878745.pdf [firstpage_image] =>[orig_patent_app_number] => 10239783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1298227 [patent_doc_number] => 06627635 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-30 [patent_title] => 'Method of preventing abuse of opioid dosage forms' [patent_app_type] => B2 [patent_app_number] => 09/815162 [patent_app_country] => US [patent_app_date] => 2001-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14797 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627635.pdf [firstpage_image] =>[orig_patent_app_number] => 09815162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6756385 [patent_doc_number] => 20030004162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Use of glycogen phosphorylase inhibitors' [patent_app_type] => new [patent_app_number] => 09/813335 [patent_app_country] => US [patent_app_date] => 2001-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33368 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004162.pdf [firstpage_image] =>[orig_patent_app_number] => 09813335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6986670 [patent_doc_number] => 20010036502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'Oil composition' [patent_app_type] => new [patent_app_number] => 09/809192 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5282 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036502.pdf [firstpage_image] =>[orig_patent_app_number] => 09809192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1202821 [patent_doc_number] => 06720312 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-13 [patent_title] => 'Method for controlling the membrane structure of a starch granule' [patent_app_type] => B2 [patent_app_number] => 09/808826 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3941 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720312.pdf [firstpage_image] =>[orig_patent_app_number] => 09808826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6744654 [patent_doc_number] => 20030021837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections' [patent_app_type] => new [patent_app_number] => 09/809516 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5535 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20030021837.pdf [firstpage_image] =>[orig_patent_app_number] => 09809516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1490667 [patent_doc_number] => 06417182 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Pharmaceutical compositions comprising metal complexes' [patent_app_type] => B1 [patent_app_number] => 09/802523 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6255 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417182.pdf [firstpage_image] =>[orig_patent_app_number] => 09802523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586419 [patent_doc_number] => 06358999 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-03-19 [patent_title] => 'Use of zinc tranexamate in the treatment of diabetes' [patent_app_type] => B2 [patent_app_number] => 09/799692 [patent_app_country] => US [patent_app_date] => 2001-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 2920 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358999.pdf [firstpage_image] =>[orig_patent_app_number] => 09799692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6894213 [patent_doc_number] => 20010016579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-23 [patent_title] => 'Serotonin 5-HT, receptor partial activator' [patent_app_type] => new [patent_app_number] => 09/796805 [patent_app_country] => US [patent_app_date] => 2001-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12679 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20010016579.pdf [firstpage_image] =>[orig_patent_app_number] => 09796805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702231 [patent_doc_number] => 20030225111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Therapy' [patent_app_type] => new [patent_app_number] => 10/220140 [patent_app_country] => US [patent_app_date] => 2002-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65101 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225111.pdf [firstpage_image] =>[orig_patent_app_number] => 10220140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417010 [patent_doc_number] => 06521659 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-18 [patent_title] => 'Compositions containing a substituted indolealkanoic acid and an angiotensin converting enzyme inhibitor' [patent_app_type] => B2 [patent_app_number] => 09/795161 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23200 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521659.pdf [firstpage_image] =>[orig_patent_app_number] => 09795161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1389343 [patent_doc_number] => 06548543 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Remedies or preventives containing cyclopentenone compounds as the active ingredient' [patent_app_type] => B1 [patent_app_number] => 09/763244 [patent_app_country] => US [patent_app_date] => 2001-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15982 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548543.pdf [firstpage_image] =>[orig_patent_app_number] => 09763244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521215 [patent_doc_number] => 06413994 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof' [patent_app_type] => B1 [patent_app_number] => 09/788070 [patent_app_country] => US [patent_app_date] => 2001-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8710 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413994.pdf [firstpage_image] =>[orig_patent_app_number] => 09788070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1303914 [patent_doc_number] => 06620844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-16 [patent_title] => 'Method for reducing blood insulin levels by reducing in vivo cathepsin L activity' [patent_app_type] => B2 [patent_app_number] => 09/784642 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20484 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620844.pdf [firstpage_image] =>[orig_patent_app_number] => 09784642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1533136 [patent_doc_number] => 06410543 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Method of producing a concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution' [patent_app_type] => B1 [patent_app_number] => 09/780371 [patent_app_country] => US [patent_app_date] => 2001-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5183 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410543.pdf [firstpage_image] =>[orig_patent_app_number] => 09780371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6898870 [patent_doc_number] => 20010047035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-29 [patent_title] => 'Prediction of wound healing by urinary nitrate assay' [patent_app_type] => new [patent_app_number] => 09/776926 [patent_app_country] => US [patent_app_date] => 2001-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7361 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20010047035.pdf [firstpage_image] =>[orig_patent_app_number] => 09776926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517620 [patent_doc_number] => 06500838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-31 [patent_title] => 'Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors' [patent_app_type] => B2 [patent_app_number] => 09/777316 [patent_app_country] => US [patent_app_date] => 2001-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 6991 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500838.pdf [firstpage_image] =>[orig_patent_app_number] => 09777316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1291950 [patent_doc_number] => 06630507 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Cannabinoids as antioxidants and neuroprotectants' [patent_app_type] => B1 [patent_app_number] => 09/674028 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 10213 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630507.pdf [firstpage_image] =>[orig_patent_app_number] => 09674028 [rel_patent_id] =>[rel_patent_doc_number] =>)